Works matching Moderna, Inc

Results: 259

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines.

Published in:

Expert Review of Vaccines, 2024, v. 23, n. 1, p. 914, doi. 10.1080/14760584.2024.2402955

By:

Bausch-Jurken, Mary;
Dawson, Rachel S;
Ceddia, Francesca;
Urdaneta, Veronica;
Marks, Morgan A;
Doi, Yohei

Publication type:

Article

Stevens–Johnson syndrome precipitated by Moderna Inc. COVID‐19 vaccine: a case‐based review of literature comparing vaccine and drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis.

Published in:

International Journal of Dermatology, 2022, v. 61, n. 8, p. 923, doi. 10.1111/ijd.16222

By:

Padniewski, Jessica J.;
Jacobson‐Dunlop, Erick;
Albadri, Sam;
Hylwa, Sara

Publication type:

Article

Desarrollo de un modelo de gestión de la inteligencia organizacional para la compañía Gráficas Modernas S.A.

Published in:

Universidad & Empresa, 2015, v. 17, n. 29, p. 63

By:

Lozano Oviedo, Jonathan;
González Campo, Carlos Hernán

Publication type:

Article

Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists.

Published in:

Pharmacotherapy, 2021, v. 41, n. 10, p. 837, doi. 10.1002/phar.2622

By:

Patel, Nimish;
Bouchard, Jeannette;
Oliver, Meredith B.;
Badowski, Melissa E.;
Carreno, Joseph J.

Publication type:

Article

COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma.

Published in:

Molecular & Clinical Oncology, 2023, v. 19, n. 6, p. N.PAG, doi. 10.3892/mco.2023.2692

By:

Tsutsumi, Yutaka;
Ito, Shinichi;
Horikita, Fuka;
Moriki, Asako;
Teshima, Takanori

Publication type:

Article

Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.

Published in:

2021

By:

Abbasi, Jennifer

Publication type:

journal article

mRNA-1273 COVID-19 vaccine-induced Steven–Johnson syndrome.

Published in:

QJM: An International Journal of Medicine, 2023, v. 116, n. 3, p. 247, doi. 10.1093/qjmed/hcac282

By:

Lo, Hung-Kai;
Lin, Yu-Chieh;
Chen, Hung-Ming;
Hsiao, Po-Jen

Publication type:

Article

Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.

Published in:

Dermatology & Therapy, 2021, v. 11, n. 6, p. 1889, doi. 10.1007/s13555-021-00610-z

By:

Diotallevi, Federico;
Campanati, Anna;
Radi, Giulia;
Martina, Emanuela;
Rizzetto, Giulio;
Barbadoro, Pamela;
D'Errico, Marcello Mario;
Offidani, Annamaria

Publication type:

Article

COVID-19: Characteristics and Therapeutics.

Published in:

Cells (2073-4409), 2021, v. 10, n. 2, p. 206, doi. 10.3390/cells10020206

By:

Chilamakuri, Rameswari;
Agarwal, Saurabh

Publication type:

Article

Moderna announces it has shipped variant-specific vaccine candidate, mRNA-1273.351, to NIH for clinical study: Company also provides update on strategy for addressing SARS-CoV-2 variants of concern.

Published in:: Rhode Island Medical Journal, 2021, v. 104, n. 2, p. 90
Publication type:: Article

COVID-19 vaccination campaigns take shape.

Published in:

American Journal of Health-System Pharmacy, 2021, v. 78, n. 4, p. 282, doi. 10.1093/ajhp/zxab019

By:

Traynor, Kate

Publication type:

Article

Towards a Prophylactic Vaccine for the Prevention of HCMV Infection.

Published in:

Vaccines, 2021, v. 9, n. 9, p. 968, doi. 10.3390/vaccines9090968

By:

Ligat, Gaëtan;
Alain, Sophie;
Hantz, Sébastien

Publication type:

Article

A response to "Indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults".

Published in:

Current Medical Research & Opinion, 2025, v. 41, n. 5, p. 921, doi. 10.1080/03007995.2025.2504627

By:

Beck, Ekkehard;
Georgieva, Mihaela;
Van de Velde, Nicolas;
Patterson-Lomba, Oscar;
Mu, Fan

Publication type:

Article

Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines.

Published in:

Expert Review of Vaccines, 2022, v. 21, n. 3, p. 281, doi. 10.1080/14760584.2022.2019020

By:

Moro, Pedro L.;
McNeil, Michael M.

Publication type:

Article

Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.

Published in:

2022

By:

Li, Jennifer Chen;
Siglin, Jonathan;
Marshall, Michael S;
Stemmer-Rachamimov, Anat;
Bloom, Seth M;
Blumenthal, Kimberly G

Publication type:

Case Study

A Response to: Letter to the Editor Regarding "Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults".

Published in:

Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2457, doi. 10.1007/s40121-024-01039-5

By:

Georgieva, Mihaela;
Sun, Tianyu;
Beck, Ekkehard

Publication type:

Article

A Response to: A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework'.

Published in:

Infectious Diseases & Therapy, 2024, v. 13, n. 10, p. 2195, doi. 10.1007/s40121-024-01020-2

By:

Beck, Ekkehard;
Bausch-Jurken, Mary T.;
Van de Velde, Nicolas;
Wang, Xuan;
Malmenäs, Mia

Publication type:

Article

2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S84, doi. 10.1093/ofid/ofz359.182

By:

Jagger, Brett W;
Dowd, Kimberly A;
Chen, Rita;
Desai, Pritesh;
Himansu, Sunny;
Graham, Barney S;
Pierson, Theodore C;
Diamond, Michael S

Publication type:

Article

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine.

Published in:

Neonatology Today, 2020, v. 15, n. 12, p. 96

By:

Goldstein, Mitchell

Publication type:

Article

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.

Published in:

MMWR: Morbidity & Mortality Weekly Report, 2021, v. 69, n. 51/52, p. 1653, doi. 10.15585/mmwr.mm695152e1

By:

Oliver, Sara E.;
Gargano, Julia W.;
Marin, Mona;
Wallace, Megan;
Curran, Kathryn G.;
Chamberland, Mary;
McClung, Nancy;
Campos-Outcalt, Doug;
Morgan, Rebecca L.;
Mbaeyi, Sarah;
Romero, José R.;
Talbot, H. Keipp;
Lee, Grace M.;
Bell, Beth P.;
Dooling, Kathleen

Publication type:

Article

Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans.

Published in:

2022

By:

Dickerman, Barbra A.;
Madenci, Arin L.;
Gerlovin, Hanna;
Kurgansky, Katherine E.;
Wise, Jessica K.;
Figueroa Muñiz, Michael J.;
Ferolito, Brian R.;
Gagnon, David R.;
Gaziano, J. Michael;
Cho, Kelly;
Casas, Juan P.;
Hernán, Miguel A.

Publication type:

journal article

665-P: Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs. 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-665-P

By:

BUSE, JOHN B.;
AUERBACH, PERNILLE;
BAJAJ, HARPREET S.;
FUKUSHIMA, YASUSHI;
LINGVAY, ILDIKO;
MACURA, STANISLAVA;
SØNDERGAARD, ANETTE L.;
TANKOVA, TSVETALINA;
TENTOLOURIS, NIKOLAOS;
FRIAS, JUAN P.

Publication type:

Article

65-LB: Real-World Continuous Glucose Monitoring Data on Time-in-Range from a U.S. Population, 2015–2019.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-65-LB

By:

BERGENSTAL, RICHARD M.;
HACHMANN-NIELSEN, ELISE;
TARP, JENS;
KVIST, KAJSA;
BUSE, JOHN B.

Publication type:

Article

101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-101-OR

By:

FRIAS, JUAN P.;
AUERBACH, PERNILLE;
BAJAJ, HARPREET S.;
FUKUSHIMA, YASUSHI;
LINGVAY, ILDIKO;
MACURA, STANISLAVA;
SØNDERGAARD, ANETTE L.;
TANKOVA, TSVETALINA;
TENTOLOURIS, NIKOLAOS;
BUSE, JOHN B.

Publication type:

Article

Phase 3 Trial of Combination Flu/SARS-CoV-2 Vaccine Meets All Primary Endpoints: Moderna.

Published in:

Patient Care (Online), 2024, p. 3

By:

Halsey, Grace

Publication type:

Article

FDA Approves Moderna's mRESVIA, First mRNA Vaccine Against RSV, for Adults Aged ≥60 Years.

Published in:: Patient Care (Online), 2024, p. 3
Publication type:: Article

Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results.

Published in:

Patient Care (Online), 2024, p. 1

By:

Meara, Killian

Publication type:

Article

Tramadol versus codéine.

Published in:

Médecine, 2022, v. 18, n. 1, p. 13, doi. 10.1684/med.2022.729

By:

Gerson, Michel

Publication type:

Article

In Pflzer We Trust?

Published in:

Social Policy, 2020, v. 50, n. 4, p. 86

By:

Mattera, Philip

Publication type:

Article

THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.

Published in:

Transactions of the American Clinical & Climatological Association, 2023, v. 133, p. 103

By:

GRAHAM, BARNEY S.

Publication type:

Article

Moderna, Pfizer Vaccines Work Better in Men: New Research.

Published in:: Indian Practitioner, 2021, v. 74, n. 5, p. 46
Publication type:: Article

Baby Born to Partially Vaccinated Mother Has Covid Antibodies.

Published in:: Indian Practitioner, 2021, v. 74, n. 3, p. 51
Publication type:: Article

Stéphane Bancel.

Published in:: Nature Reviews Drug Discovery, 2015, v. 14, n. 6, p. 378, doi. 10.1038/nrd4646
Publication type:: Article

Self-Reported Reactogenicity After Different COVID-19 Vaccination Regimens: An Analysis of Registry-Based Data.

Published in:

Deutsches Ärzteblatt International, 2022, v. 119, n. 43, p. 727, doi. 10.3238/arztebl.m2022.0298

By:

Pfrommer, Laura R.;
Schoeps, Melissa;
Blettner, Maria;
Wollschläger, Daniel;
Herm-Stapelberg, Nils;
Mittnacht, Lukas;
Kachel, Philipp;
Jahn, Klaus;
von Loewenich, Friederike D.;
Gianicolo, Emilio A. L.

Publication type:

Article

INNOVATIVE RESILIENCE: ASSESSING VACCINE PORTFOLIO PERFORMANCE DURING THE PANDEMIC THROUGH ALTERNATIVE DATA SOURCES.

Published in:

Applied Research in Studies & Practice / Taikomieji Tyrimai Studijose ir Praktikoje, 2024, v. 20, n. 1, p. 259

By:

ŽUKAUSKIENĖ, Sandra;
ŽUKAUSKAS, Tadas

Publication type:

Article

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.

Published in:

2021

By:

Chapin-Bardales, Johanna;
Gee, Julianne;
Myers, Tanya

Publication type:

journal article

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

Published in:

2021

By:

Shimabukuro, Tom T.;
Cole, Matthew;
Su, John R.

Publication type:

journal article

Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.

Published in:

JAMA: Journal of the American Medical Association, 2021, v. 325, n. 9, p. 898, doi. 10.1001/jama.2021.1375

By:

Livingston, Edward H.

Publication type:

Article

COVID-19 Vaccine-induced Skin Rash: A Case Study.

Published in:

2021

By:

Porwal, Tulika;
Agarwal, Anshul

Publication type:

Case Study

market solutions.

Published in:: 2007
Publication type:: Product Review

Big Pharma and Omicron.

Published in:

CounterPunch, 2021, p. 1

By:

Pramas, Jason

Publication type:

Article

Why Moderna Refuses to Share Rights to the COVID-19 Vaccine With the Government That Paid for Its Development.

Published in:

CounterPunch, 2021, p. 1

By:

Rutschman, Ana Santos

Publication type:

Article

Why Are Moderna's Billionaires Airbrushing Scientists Out of the Vaccine Patent Picture?

Published in:

CounterPunch, 2021, p. 1

By:

Pizzigati, Sam

Publication type:

Article

An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccination.

Published in:

2021

By:

Manci, R. N.;
Jennings, T.;
Mclarney, R. M.;
Heymann, W. R.;
Sommer, L. L.

Publication type:

Case Study

Business: The billion-dollar biotech.

Published in:

Nature, 2015, v. 522, n. 7554, p. 26, doi. 10.1038/522026a

By:

Dolgin, Elie

Publication type:

Article

Moderna's $450-million venture round.

Published in:: Nature Biotechnology, 2015, v. 33, n. 2, p. 119, doi. 10.1038/nbt0215-119d
Publication type:: Article

Clinical burden of propionic acidemia in the United States: a claims-based study by age stratum.

Published in:

Orphanet Journal of Rare Diseases, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13023-025-03901-2

By:

Banerjee, Geetanjoli;
Perera, Sue;
Mu, Fan;
Cook, Erin;
Cheng, Mu;
Zhang, Adina;
Lan, Jessie Jie;
Zou, Lin;
Sikirica, Vanja

Publication type:

Article

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60938-4

By:

Rudman Spergel, Amanda K.;
Lee, Ivan T.;
Koslovsky, Kindra;
Schaefers, Kristi;
Avanesov, Andrei;
Logan, Douglas K.;
Hemmersmeier, John;
Ensz, David;
Stadlbauer, Daniel;
Hu, Bo;
Pucci, Alicia;
Vakil, Jignesh;
Paris, Robert;
Ananworanich, Jintanat;
Nachbagauer, Raffael

Publication type:

Article

Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60057-0

By:

Meyer, Michelle;
Gunn, Bronwyn M.;
Pietzsch, Colette;
Subramani, Chandru;
Kedarinath, Kritika;
Villarreal, Paula P.;
Hyde, Matthew A.;
Saphire, Erica Ollmann;
Crowe Jr., James E.;
Alter, Galit;
Himansu, Sunny;
Carfi, Andrea;
Bukreyev, Alexander

Publication type:

Article